Delivery Order SPE2DB24D2205-SPE2DB24FDSGD
Award Date
4/8/24
Potential Completion Date
4/9/24
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $1,668.08 and a performance period through April 11, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,246.00 Firm Fixed Price delivery order is for the supply of 4,566,208,979 units of ONFI 10 MG TABLET, with an ultimate completion date of October 28, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,374.45, is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This $8,679.22 delivery order was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4566087993 ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price and does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for providing a...
This is a $1,774.08 firm fixed-price delivery order contract awarded by the Department of Defense's Medical Supply Chain (97AS) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,564,286,930 units of the prescription medication ONFI 10 MG TABLET 100S, with a completion date of April 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,683.44, is a firm fixed-price delivery order for 4,568,105,655 units of the pharmaceutical product ONFI 10 MG TABLET 100S. The contract has an ultimate completion date of May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,596.30 firm fixed price delivery order contract to supply 4,564,159,068 ONFI 10 MG tablets in 100-count packages. This award is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,050.32, is a delivery order with a firm fixed price. It is for the supply of ONFI 10 MG TABLET 100S, a pharmaceutical product, with an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ONFI 10 MG TABLET 100S. The contract has a ceiling value of $3,336.16 and a completion date of June 6, 2024. It is a firm-fixed-price contract, which indicates the price is set and not subject to adjustment. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ONFI 10 MG TABLET 100S. The firm-fixed-price contract, valued at $2,037.53, has an ultimate completion date of August 14, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support...